Institutional Repository of Vilnius University
NOTCH signalinio kelio komponentų raiškos pokyčių kiekybinis įvertinimas kiaušidžių vėžiu sergančių pacienčių audiniuose /
Abstract
dc:descriptionOvarian cancer is one of the most frequently diagnosed and deadliest malignant gynecologic pathologies. This is because it is often diagnosed at an advanced stage (known as high-grade serous carcinoma, HGSOC) and does not have specific symptoms or well-established biomarkers. Currently utilized biomarkers in the clinic, CA-125 and HE4, have limitations. For example, CA 125 has low sensitivity for detecting early-stage ovarian cancer, and HE4 testing is not recommended in routine practice due to contradictory studies. Components of the NOTCH signaling pathway, which control various processes occuring in healthy and cancerous cells, may become potential biomarkers for ovarian cancer. During the bachelor‘s thesis, 66 ovarian tissue samples were analyzed, divided into three groups: HGSOC, other gynecological tumors and benign gynecological tumors. Changes in the expression of NOTCH signaling pathway ligands JAG2, DLL1 and the target HES1 were examined by the RT-qPCR method. It was estimated, that the expression of JAG2, DLL1 and HES1 genes was lower in HGSOC samples compared to benign gynecological tumor tissues, and the downregulation in DLL1 and HES1 genes expression between groups was statistically significant. A statistically significant decrease in DLL1 and HES1 genes expression was found between HGSOC and other gynecologic tumor tissue samples, with a tendency towards a difference in DLL1 gene expression observed between other gynecologic and benign gynecologic tumor tissue samples. The study found statistically significant links between the changes in the expression of the studied genes and the stage of the tumor, blood serum biomarker CA-125, and tumor differentiation grade, while no statistically significant associations were found with the age of the patients or the radical disease after surgery. The results of the study indicate that the NOTCH signaling pathway genes may become promising biomarkers for future ovarian cancer diagnostics.
Degree
thesis:*- Grantor dc:publisher
- Institutional Repository of Vilnius University
- Year dc:date
- 2024
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Kazlauskaitė, Paulina,
Rights
dc:rights- Statement dc:rights
-
- info:eu-repo/semantics/openAccess
- Language dc:language
- lit
Identifiers
dc:identifier.*- Repository record dc:identifier
- https://repository.vu.lt/VU:ELABAETD210637781&prefLang=en_US